Quarterly report pursuant to Section 13 or 15(d)

Schedule of Anti-dilutive Effect (Details)

v3.23.3
Schedule of Anti-dilutive Effect (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 375,811 54,510 375,811 54,510
Equity Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 62,589 26,642 62,589 26,642
Restricted Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 1,079 1,630 1,079 1,630
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 312,143 26,238 312,143 26,238